Psoriasis of Scalp Clinical Trial
Official title:
Calcipotriol Plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients With Scalp Psoriasis
The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of
calcipotriol plus betamethasone dipropionate gel is more effective than twice daily
treatment of calcipotriol scalp solution in patients with scalp psoriasis. The primary
outcome is patients with clear or minimal disease after 8 weeks treatment.
Further the occurrence of relapse and rebound after end of treatment in patients with clear
or minimal disease will be investigated.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05144165 -
Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines
|
||
| Completed |
NCT05105139 -
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
|
||
| Completed |
NCT00216827 -
Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Recruiting |
NCT04099979 -
A Pilot Study to Explore the Role of Gut Flora in Psoriasis
|
||
| Not yet recruiting |
NCT03553433 -
Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
|
Phase 4 | |
| Recruiting |
NCT05938361 -
Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
|
||
| Recruiting |
NCT05858632 -
Immune Spatial Features of Guselkumab Cutaneous Response
|
Phase 4 | |
| Completed |
NCT00216879 -
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT00216840 -
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis
|
Phase 3 |